参考文献/References:
[1] Scott DL,Wolfe F,Huizinga TW. Rheumatoid arthritis[J]. Lancet,2010,376(9746):1094-1108.
[2] Dai SM,Han XH,Zhao DB,et al. Prevalence of rheumatic symptoms,rheumatoid arthritis,ankylosing spondylitis,and gout in Shanghai,China:A COPCORD study[J]. J Rheumatol,2003,30(10):2245-2251.
[3] Wright K,Crowson CS,Gabriel SE. Cardiovascular comorbidity in rheumatic diseases[J]. Heart Fail Clin,2014,10(2):339-352.
[4] Dudek M,Ka?u?na-Oleksy M,Migaj J,et al. Difficult diagnosis of heart failure in rheumatoid arthritis:six-year follow-up of constrictive pericarditis[J]. Kardiol Pol,2018,76(3):675.
[5] Afonina ZA,Myasnikov AG,Shirokov VA,et al. Formation of circular polyribosomes on eukaryotic mRNA without cap-structure and poly(A)-tail:a cryo electron tomography study[J]. Nucleic Acids Res,2014,42(14):9461-9469.
[6] Burd CE,Jeck WR,Liu Y,et al. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk[J]. PLoS Genet,2010,6(12):e1001233.
[7] Li F,Zhang L,Li W,et al. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway[J]. Oncotarget,2015,6(8):6001-6013.
[8] Ouyang Q,Wu J,Jiang Z,et al. Microarray expression profile of circular RNAs in peripheral blood mononuclear cells from rheumatoid arthritis patients[J]. Cell Physiol Biochem,2017,42(2):651-659.
[9] Bai Y,Zhang Y,Han B,et al. Circular RNA DLGAP4 amelioratesischemic stroke outcomes by targeting miR-143 to regulate endothelial-mesenchymal transition associated with blood-brain barrier integrity[J]. J Neurosci,2018,38(1):32-50.
[10] Villeneuve E,Nam J,Emery P. 2010 ACR-EULAR classification criteria for rheumatoid arthritis[J]. Rev Bras Reumatol,2010,50(5):481-483.
[11] Pierce JD,Dalton K,Duke K,et al. Heart failure guidelines and implications for surgically treating heart failure[J]. AORN J,2009,90(6):874-888.
[12] Scott DL,Wolfe F,Huizinga TWJ. Rheumatoid arthritis[J]. Lancet,2010,376(9746):1094-1108.
[13] Baniaamam M,Paulus WJ,Blanken AB,et al. The effect of biological DMARDs on the risk of congestive heart failure in rheumatoid arthritis:a systematic review[J]. Expert Opin Biolog Ther,2018,18(5)1:585-597.
[14] Giles JT,Malayeri AA,Fernandes V,et al. Left ventricular structure and function in patients with rheumatoid arthritis,as assessed by cardiac magnetic resonance imaging[J]. Arthritis Rheum,2010,62(4):940-951.
[15] Crowson CS,Myasoedova E,Davis JM 3rd,et al. Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease[J]. Arthritis Care Res (Hoboken),2011,63(5):729-734.
[16] Qu S,Yang X,Li X,et al. Circular RNA:a new star of noncoding RNAs[J]. Cancer lett,2015,365(2):141-148.
[17] Tang X,Wang J,Xia X,et al. Elevated expression of ciRS-7 in peripheral blood mononuclear cells from rheumatoid arthritis patients[J]. Diagn Pathol,2019,14(1):11.
[18] Zheng F,Yu X,Huang J,et al. Circular RNA expression profiles of peripheral blood mononuclear cells in rheumatoid arthritis patients,based on microarray chip technology[J]. Mol Med Rep,2017,16(6):8029-8036.
[19] Yang Z,Wang J,Pan Z,et al. miR-143-3p regulates cell proliferation and apoptosis by targeting IGF1R and IGFBP5 and regulating the Ras/p38 MAPK signaling pathway in rheumatoid arthritis[J]. Exp Ther Med,2018,15(4):3781-3790.
相似文献/References:
[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(8):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(8):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(8):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(8):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(8):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on
Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(8):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(8):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(8):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[9]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(8):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[10]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(8):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]